First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Danaher Corporation

    DHR · 6 developments mapped · last assessed 2026-09-29

    Market Ontology has mapped 6 macro, policy, and market developments to Danaher Corporation since 2026-08-20. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for DHR yet, so no modelled value is shown. The DHR valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run DHR on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for DHR. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      Automated AI Microscopy Sector Projected to Reach $16.63B by 2035 at 7.35% CAGR

      Increased demand for life science and diagnostics tools, including microscopy and imaging solutions, where Danaher has a significant presence through its subsidiaries.

      · Moves long term revenue growth rate, segment growth expectations

    • Open question

      Merck KGaA to acquire Bio-Techne Corporation for $73.00 per share in cash

      Potential re-evaluation of sector valuations and competitive landscape.

      · Moves sector m&a premium, competitive positioning in life sciences tools

    What changed, by assumption

    Long term revenue growth rate
    • 2026-09-23Automated AI Microscopy Sector Projected to Reach $16.63B by 2035 at 7.35% CAGR
    Revenue growth rate
    • 2026-09-21Magnetic Bead Purification Market Forecast to Expand at 10.5% CAGR to $6.73B by 2030
    Sector m&a premium
    • 2026-08-20Merck KGaA to acquire Bio-Techne Corporation for $73.00 per share in cash
    Growth rate of life sciences segment
    • 2026-09-23Roche Reports 15.5% Weight Loss in Phase II Trial of Dual GLP-1/GIP Agonist Enicepatide
    Segment specific growth rates
    • 2026-09-17Envista Holdings Corporation Hosts 2026 Investor Day

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-29Quantum-Si Interim Proteus Data Shows 30x Alignment Gain Over Platinum Prowatch3-12m0.20
    2026-09-23Automated AI Microscopy Sector Projected to Reach $16.63B by 2035 at 7.35% CAGRBullish1-5y0.65
    2026-09-23Roche Reports 15.5% Weight Loss in Phase II Trial of Dual GLP-1/GIP Agonist Enicepatidemixed3-12m0.30
    2026-09-21Magnetic Bead Purification Market Forecast to Expand at 10.5% CAGR to $6.73B by 2030Bullish1-5y0.60
    2026-09-17Envista Holdings Corporation Hosts 2026 Investor Daywatch1-3m0.30
    2026-08-20Merck KGaA to acquire Bio-Techne Corporation for $73.00 per share in cashmixed1-3m0.40